FDA Adverse Event Injury Summary report: N

SPECTRUM TURBO-JECT ANTIBIOTIC POWER INJECTABLE PICC

MDR report key: 13064133 · Received December 22, 2021

Report

Report Number
1820334-2021-02733
Event Type
Injury
Date Received
December 22, 2021
Date of Event
December 10, 2021
Report Date
October 6, 2022
Manufacturer
COOK INC
Product Code
LJS
PMA / PMN Number
K133634
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

D2A - ADDITIONAL COMMON DEVICE NAME: FOZ CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS. D2B - ADDITIONAL PRO CODE: FOZ. THIS REPORT INCLUDES INFORMATION KNOWN AT THIS TIME. A FOLLOW UP REPORT WILL BE SUBMITTED SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE. THIS REPORT IS REQUIRED BY THE FDA UNDER 21 CFR PART 803. THIS REPORT IS BASED ON UNCONFIRMED INFORMATION SUBMITTED BY OTHERS. NEITHER THE SUBMISSION OF THIS REPORT NOR ANY STATEMENT MADE IN IT IS INTENDED TO BE AN ADMISSION THAT ANY COOK DEVICE IS DEFECTIVE OR MALFUNCTIONED; THAT A DEATH OR SERIOUS INJURY OCCURRED; OR THAT ANY COOK DEVICE CAUSED OR CONTRIBUTED TO; OR IS LIKELY TO CAUSE OR CONTRIBUTE TO A DEATH OR SERIOUS INJURY IF A MALFUNCTION OCCURRED.

Additional Manufacturer Narrative · 0

BLANK FIELDS ON THIS FORM INDICATE THE INFORMATION IS UNKNOWN, UNAVAILABLE, OR UNCHANGED. CORRECTION: H6- ANNEX A INVESTIGATION ¿ EVALUATION. (B)(6) HOSPITAL (UNITED STATES) INFORMED COOK THAT ON (B)(6) 2021 THE PICC (PERIPHERALLY INSERTED CENTRAL CATHETER) IN A UPICS-3.0-CT-NT-ABRM-1110 (SPECTRUM TURBO-JECT ANTIBIOTIC POWER INJECTABLE PICC) FROM AN UNKNOWN LOT WAS CRACKING. THE PATIENT REQUIRED AN INTERVENTIONAL RADIOLOGY PROCEDURE FOR A PICC REPLACEMENT. REVIEWS OF THE COMPLAINT HISTORY, QUALITY CONTROL, AND INSTRUCTIONS FOR USE (IFU), WERE CONDUCTED DURING THE INVESTIGATION. THE COMPLAINT DEVICE WAS NOT RETURNED; THEREFORE, NO PHYSICAL EXAMINATIONS COULD BE PERFORMED. HOWEVER, A DOCUMENT-BASED INVESTIGATION EVALUATION WAS PERFORMED. A REVIEW OF THE DEVICE MASTER RECORD (DMR) CONCLUDED THAT SUFFICIENT INSPECTION ACTIVITIES ARE IN PLACE TO IDENTIFY THIS FAILURE MODE PRIOR TO DISTRIBUTION. A REVIEW OF THE DEVICE HISTORY RECORD (DHR) WAS UNABLE TO BE COMPLETED DUE TO A LACK OF LOT INFORMATION. COOK REVIEWED THE SALES HISTORY FOR THIS CUSTOMER AND WAS UNABLE TO IDENTIFY THE COMPLAINT LOT. BASED ON THE AVAILABLE INFORMATION, COOK HAS CONCLUDED THAT THE DEVICE WAS MANUFACTURED TO SPECIFICATION AND THAT THERE IS NO EVIDENCE SUGGESTING NONCONFORMING PRODUCT EXISTS EITHER IN HOUSE OR IN FIELD. COOK ALSO REVIEWED PRODUCT LABELING. THE PRODUCT IFU, [T_UPICABRMTT_REV1] ¿COOK SPECTRUM TURBO-JECT PERIPHERALLY INSERTED CENTRAL VENOUS CATHETERS WITH MICROPUNCTURE PEEL-AWAY INTRODUCERS,¿ PROVIDES THE FOLLOWING INFORMATION TO THE USER RELATED TO THE REPORTED FAILURE MODE: INTENDED USE: ¿THE MAXIMUM PRESSURE LIMIT SETTING FOR POWER INJECTORS USED WITH THE SPECTRUM TURBO-JECT PICC MAY NOT EXCEED 325 PSI AND THE FLOW RATE MAY NOT EXCEED THE MAXIMUM FLOW RATE INDICATED, AS SHOWN ON THE FOLLOWING TABLE.¿ WARNINGS ¿-THE SAFE AND EFFECTIVE USE OF TURBO-JECT PICC LINES WITH POWER INJECTOR PRESSURES SET ABOVE 325 PSI HAS NOT BEEN ESTABLISHED. -DO NOT POWER INJECT IF MAXIMUM INJECTION RATE CANNOT BE VERIFIED TO MEET LIMIT PRINTED ON CATHETER HUB OR EXTENSION TUBE. -TO SAFELY USE TURBO-JECT PICC LINES WITH A POWER INJECTOR, THE TECHNICIAN/HEALTH CARE PROFESSIONAL MUST VERIFY: THE CATHETER LUMEN HAS ¿CT¿ ON THE HUB TO INDICATE THE LUMEN IS POWER INJECTABLE. PRIOR TO USE THAT THE MAXIMUM PRESSURE LIMIT IS SET AT OR BELOW 325 PSI AND THAT THE MAXIMUM FLOW RATE IS AT OR BELOW THAT WHICH IS LISTED ON THE CATHETER. DYNAMIC AND STATIS PRESSURE TEST RESULTS ARE SHOWN IN THE FOLLOWING TABLE. [4FR SINGLE HUB HAS A 0.76 ML PRIMING VOLUME, 5ML/SEC LABELED FLOW RATE, 177 PSI MAXIMUM FLOW, 226 PSI 37 DEGREES CELSIUS AVERAGE STATIC BURST WATER PRESSURE, 217-233 PSI 37 DEGREES CELSIUS RANGE STATIC BURST PRESSURE.] MAXIMUM FLOW RATE PRESSURES ARE DETERMINED WITH PUMP SAFETY CUT-OFF SET AT 325 PSI, USING CONTRAST MEDIA WITH A VISCOSITY OF 11.8 CP. STATIC BURST PRESSURE IS THE FAILURE POINT OF THE CATHETER WHEN TOTALLY OCCLUDED. WARNING: POWER INJECTOR MACHINE PRESSURE LIMITING FEATURE MAY NOT PREVENT OVER PRESSURIZATION OF AN OCCLUDED CATHETER.¿ PRECAUTIONS: -IF LUMEN FLOW IS IMPEDED, DO NOT FORCE INJECTION OR WITHDRAWAL OF FLUIDS. NOTIFY ATTENDING PHYSICIAN IMMEDIATELY. -PATIENT MOVEMENT CAN CASE CATHETER TIP DISPLACEMENT. CATHETERS PLACES VIA AN ANTECUBITAL VEIN HAVE SHOWN TIP MOVEMENT OF UP TO 10 CM WITH MOTION OF THE EXTREMITY. -CATHETER SIZE SHOULD BE AS SMALL AS THE USE WILL ALLOW. INSTRUCTIONS FOR USE: POWER INJECTION PROCEDURE ¿3. REMOVE ANY INJECTION/NEEDLESS CAPS FROM THE SPECTRUM TURBO-JECT PICC. 4. ATTACH A 10ML (OR LARGER) SYRINGE FILLED WITH STERILE NORMAL SALINE TO THE HUB OF THE EXTENSION TUBE TO BE USED FOR POWER INJECTION. 5. ENSURE ADEQUATE BLOOD RETURN AND FLUSH CATHETER VIGOROUSLY WITH THE ENTIRE 10 ML OF STERILE NORMAL SALINE TO ENSURE LUMEN PATENCY. WARNING: FAILURE TO ENSURE PATENCY OF THE CATHETER LUMEN PRIOR TO INJECTION MAY RESULT IN CATHETER FAILURE. 6. REMOVE SYRINGE AND ATTACH POWER INJECTION DEVICE TO THE CATHETER USING THE MANUFACTURER¿S RECOMMENDATIONS. 7. CONDUCT STUDY USING THE POWER INJECTOR, MAKING SURE NOT TO EXCEED THE MAXIMUM FLOWRATE OR PRESSURE LIMIT FOR THE CATHETER. 8. DISCONNECT THE POWER INJECTION DEVICE AND FLUSH THE CATHETER AGAIN WITH 10 ML OF STERILE NORMAL SALINE. 9. PLACE A NEW INJECTION/NEEDLELESS CAP ON THE SPECTRUM TURBO-JECT PICC, FLUSH AND LOCK THE CATHETER WITH SALINE OR HEPARINIZED SALINE PER INSTITUTIONAL PROTOCOL.¿ HOW SUPPLIED: ¿SUPPLIED STERILIZED BY ETHYLENE OXIDE GAS IN PEEL-OPEN PACKAGES. INTENDED FOR ONE-TIME USE. STERILE IF PACKAGING IS UNOPENED OR UNDAMAGED. DO NOT USE THE PRODUCT IF THERE IS DOUBT AS TO WHETHER THE PRODUCT IS STERILE. STORE IN A DARK, DRY, COOL PLACE. AVOID EXTENDED EXPOSURE TO LIGHT. UPON REMOVAL FROM PACKAGE, INSPECT THE PRODUCT TO ENSURE NO DAMAGE HAS OCCURRED.¿ BASED ON THE AVAILABLE INFORMATION, NO DEVICE RETURN, AND THE RESULTS OF THE INVESTIGATION, COOK HAS CONCLUDED THAT PRODUCT ISSUE IS RELATED TO DEVICE DESIGN. APPROPRIATE MEASURES HAVE BEEN TAKEN TO ADDRESS THIS FAILURE MODE. THIS PRODUCT FAILURE WAS PREVIOUSLY INVESTIGATED UNDER CAPA 154487. THE CAPA INVESTIGATION FOUND THAT THE ROOT CAUSE IS RELATED TO INADEQUATE FLEXURAL STRENGTH IN A PREVIOUS HUB DESIGN CHANGE. INVESTIGATION FURTHER FOUND THAT THE DEVICES WERE MANUFACTURED TO SPECIFICATION AND THERE WAS NO EVIDENCE OF LOT-RELATED ISSUES. THE APPROPRIATE PERSONNEL HAVE BEEN NOTIFIED. COOK WILL CONTINUE TO MONITOR FOR SIMILAR COMPLAINTS. PER THE RISK ASSESSMENT NO FURTHER ACTION IS REQUIRED. THIS REPORT IS REQUIRED BY THE FDA UNDER 21 CFR PART 803 AND IS BASED ON UNCONFIRMED INFORMATION SUBMITTED BY OTHERS. NEITHER THE SUBMISSION OF THIS REPORT NOR ANY STATEMENT CONTAINED HEREIN IS INTENDED TO BE AN ADMISSION THAT ANY COOK DEVICE IS DEFECTIVE OR MALFUNCTIONED, THAT A DEATH OR SERIOUS INJURY OCCURRED, NOR THAT ANY COOK DEVICE CAUSED, CONTRIBUTED TO, OR IS LIKELY TO CAUSE OR CONTRIBUTE TO A DEATH OR SERIOUS INJURY IF A MALFUNCTION OCCURRED.

Additional Manufacturer Narrative · 0

OCCUPATION: MANAGER. THIS REPORT INCLUDES INFORMATION KNOWN AT THIS TIME. A FOLLOW UP REPORT WILL BE SUBMITTED SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE.

Additional Manufacturer Narrative · 0

THIS REPORT INCLUDES INFORMATION KNOWN AT THIS TIME. A FOLLOW UP REPORT WILL BE SUBMITTED SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE. THIS REPORT IS REQUIRED BY THE FDA UNDER 21 CFR PART 803. THIS REPORT IS BASED ON UNCONFIRMED INFORMATION SUBMITTED BY OTHERS. NEITHER THE SUBMISSION OF THIS REPORT NOR ANY STATEMENT MADE IN IT IS INTENDED TO BE AN ADMISSION THAT ANY COOK DEVICE IS DEFECTIVE OR MALFUNCTIONED; THAT A DEATH OR SERIOUS INJURY OCCURRED; OR THAT ANY COOK DEVICE CAUSED OR CONTRIBUTED TO; OR IS LIKELY TO CAUSE OR CONTRIBUTE TO A DEATH OR SERIOUS INJURY IF A MALFUNCTION OCCURRED.

Description of Event or Problem · 0

NO ADDITIONAL INFORMATION REGARDING PATIENT AND/OR EVENT DETAILS HAS BEEN RECEIVED SINCE THE PREVIOUS MEDWATCH REPORT WAS SENT.

Description of Event or Problem · 0

NO ADDITIONAL INFORMATION REGARDING THE PATIENT AND/OR EVENT HAS BEEN RECEIVED SINCE THE PREVIOUS MEDWATCH REPORT WAS SENT.

Description of Event or Problem · 0

IT WAS REPORTED THAT A COOK SPECTRUM 3 FRENCH SINGLE LUMEN PERIPHERALLY INSERTED CENTRAL CATHETER HAD CRACKED. ADDITIONAL INFORMATION HAS BEEN REQUESTED BUT WAS NOT AVAILABLE AT THE TIME OF THIS REPORT.

Description of Event or Problem · 0

ADDITIONAL INFORMATION WAS PROVIDED ON (B)(6) 2021 INDICATING THAT THE PERIPHERALLY INSERTED CENTRAL CATHETER WAS REMOVED AND REWIRED IN AN INTERVENTIONAL RADIOLOGY PROCEDURE. THE PATIENT DID NOT EXPERIENCE ANY ADVERSE EFFECTS AS A RESULT OF THE EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1963602 SPECTRUM TURBO-JECT ANTIBIOTIC POWER INJECTABLE PICC LJS TURBO-JECT PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER LJS COOK INC UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 Unknown Required Intervention